Full-Time

Director – Oncology

Scientific Consulting, Oncology Research

Posted on 9/17/2025

Aetion

Aetion

51-200 employees

Real-world evidence software for life sciences

Compensation Overview

$180k - $205k/yr

New York, NY, USA

Hybrid

Willingness to travel regularly to the New York office to foster team collaboration.

Category
Biology & Biotech (4)
, , ,
Requirements
  • Master's + 6 years experience; Doctoral degree + 4 years experience in Public Health, Epidemiology, Biostatistics, Health Economics or related field.
  • Experience designing observational studies using large US-based administrative claims or EHR data and other complex data sources
  • Expert in core epidemiologic and biostatistical principles, with a focus on pharmacoepidemiology, HEOR, and biostatistical methods applied to observational RWE studies.
  • Applied experience using US-based oncology RWD (e.g., Flatiron, ConcertAI, COTA, Tempus) to generate insights
  • Experience in leading teams including mentoring and development for junior scientific staff.
  • Proven ability to build and maintain strategic relationships with diverse stakeholders, including clients, partners, and cross-functional teams, through in-person meetings, virtual engagements, and written communication
  • Exceptional written and verbal English communication skills, with the ability to convey ideas clearly and effectively.
Responsibilities
  • Lead the overall scientific and analytic services provided to portfolio clients, ensuring alignment with their needs and objectives.
  • Provide expert scientific and strategic guidance on study designs, analysis approaches, and research methodology to both internal teams and clients, with emphasis on oncology.
  • Oversee operational objectives, strategy development, and budget management to deliver exceptional solutions across client portfolios.
  • Mentor and manage a growing scientific team, helping them achieve performance goals and advancing their professional development.
  • Collaborate with cross-functional department leaders to define strategic business goals and drive informed decision-making.
  • Contribute to external thought leadership, including conference abstract submissions, manuscript authorship, participation in webinars, and engagement with professional societies.
Desired Qualifications
  • Track record of substantive publications and presentations at scientific conferences.
  • Excellent time management skills, with the ability to juggle multiple priorities and deliver high-quality results.
  • Exceptional attention to detail and a proactive, problem-solving mindset.
  • Creative thinking and the ability to identify and recommend innovative solutions.
  • Proven experience in non-interventional studies and impactful publications.
  • Willingness to travel regularly to the New York office to foster team collaboration, with flexibility for conferences.

Aetion builds software that helps life sciences companies, regulators, and purchasers analyze real-world data to understand how medical interventions perform in real patient care. Its platform and apps manage longitudinal health data and can generate synthetic data using AI, enabling hypothesis testing, analysis, and ongoing safety monitoring, with additional data science and regulatory services. The solution emphasizes end-to-end real-world data workflows and rapid, ROI-focused insights that streamline decision-making. The goal is to maximize value from real-world data and speed informed decisions to improve patient care.

Company Size

51-200

Company Stage

Series C

Total Funding

$203.6M

Headquarters

New York City, New York

Founded

2012

Simplify Jobs

Simplify's Take

What believers are saying

  • Datavant acquisition completed July 2025 creates end-to-end RWE platform, doubling life sciences team and expanding addressable market.[1]
  • AWS Marketplace integration March 2025 removes procurement barriers and enables scalable cloud-based evidence generation for global customers.[2]
  • Barcelona technology hub doubled engineering capacity, developing Aetion Discover for visual-first exploratory analysis workflows.[3]

What critics are saying

  • Datavant integration erodes Aetion's standalone brand, driving client attrition to competitors like IQVIA within 6-12 months.[6]
  • FDA regulatory rejection of synthetic health data blocks life sciences revenue, forcing clients to compliant alternatives.[6]
  • Barcelona hub attrition after rapid scaling enables Komodo Health to outpace Aetion in rapid-cycle analytics capabilities.[6]

What makes Aetion unique

  • Aetion's rapid-cycle analytics technology uniquely transforms real-world clinical and financial data into regulatory-grade evidence quickly.[1][5]
  • Combined Datavant-Aetion ecosystem spans 300+ data partners across EHRs, claims, pharmacy, registries, and social determinants.[1]
  • Aetion's AI-driven platform automates hypothesis generation and analysis, accelerating insights from complex longitudinal datasets.[6]

Help us improve and share your feedback! Did you find this helpful?

Benefits

Medical, dental, & vision insurance

Free membership to OneMedical

FSA

4% 401(k) match

Commuter benefits for parking & transit

Unlimited PTO

Paid parental leave

Wellness stipend

Company activities

Growth & Insights and Company News

Headcount

6 month growth

8%

1 year growth

13%

2 year growth

10%
Business Wire
May 16th, 2025
Datavant to Acquire Aetion, Empowering Healthcare and Life Sciences Organizations to Generate High-Quality, Scalable Real-World Evidence from Connected, Privacy-Protected Data

Datavant, a leading health data platform company, today announced that it has signed an agreement to acquire Aetion, a leading real-world evidence (RWE) plat...

Endpoints News
May 15th, 2025
Exclusive: Datavant to acquire real-world data specialist Aetion, doubling life sciences team

Exclusive: Datavant to acquire real-world data specialist Aetion, doubling life sciences team.

Endpoints News
May 15th, 2025
Datavant Acquires Aetion, Expands Team

Datavant is acquiring Aetion, a competitor in the real-world data sector, as reported exclusively by Endpoints News. This acquisition will lead to Datavant doubling its life sciences team. Further details are expected to be announced by Datavant on Thursday.

PR Newswire
Mar 31st, 2025
Aetion Launches Aetion® Evidence Platform Availability In Aws Marketplace, Accelerating Real-World Evidence Benefits For Its Customers

Aetion's industry-leading platform integrates advanced analytics, scalable workflows and actionable insights empowering organizations to unlock the full potential of their data and achieve measurable impactNEW YORK, March 31, 2025 /PRNewswire/ -- Aetion , the global leader in real-world evidence (RWE) technology and analytics, today announced the availability of its Aetion® Evidence Platform (AEP) in Amazon Web Services (AWS) Marketplace, a digital catalog with thousands of software listings from independent software vendors that make it easy to find, test, buy, and deploy software that runs on AWS. This launch removes implementation barriers, simplifies procurement and enables life sciences organizations, payers and regulators to harness scalable, cloud-based evidence generation with the security and reliability of AWS.AEP empowers organizations to analyze real-world data (RWD) to generate transparent, reproducible and regulatory-grade evidence for decision-making in drug development, market access, policy and pricing. By leveraging AWS Marketplace, Aetion streamlines access to its platform and reliable, fit-for-purpose solutions tailored to meet each organization's specific objectives, as well as accelerating time-to-insights and ensuring compliance with global regulatory standards.Aetion relies on AWS as its core infrastructure, leveraging services such as Amazon Bedrock to power its artificial intelligence and machine learning (AI/ML)-driven capabilities in order to unlock hidden insights about patient populations and translate scientific intent to results. These technologies enhance AEP's ability to process complex RWD at scale, enabling sophisticated hypothesis generation and analysis automation for evidence generation."The availability of AEP in AWS Marketplace underscores our commitment to providing scalable, high-impact solutions that help organizations make real-world data work for them," said Jay Podence, senior vice president of Commercial Partnerships at Aetion. "By integrating with AWS, we offer our new and existing customers a seamless path to deploy and scale real-world evidence studies with enhanced efficiency and security. This is the first step in our vision to expand our collaboration with AWS to bring more value to our customers

株式会社PR TIMES
Feb 19th, 2025
NEC invests in Aetion for RWD/RWE collaboration

NEC's CVC fund, NEC Orchestrating Future Fund, has invested in Aetion, Inc., a U.S. company providing a medical data analysis platform. This investment aims to enhance collaboration in utilizing real-world data (RWD) and real-world evidence (RWE) for drug development. Aetion's platform, Aetion Evidence Platform, is used globally by pharmaceutical companies and healthcare organizations to improve decision-making. NEC and Aetion will explore synergies to streamline drug development processes.

INACTIVE